Masimo - MASI Stock Forecast, Price & News

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Masimo Stock Performance

Shares of NASDAQ:MASI traded down $2.39 during trading on Thursday, reaching $155.39. The company had a trading volume of 8,926 shares, compared to its average volume of 904,110. Masimo has a 52 week low of $112.07 and a 52 week high of $305.21. The stock has a market cap of $8.62 billion, a PE ratio of 47.52 and a beta of 0.98. The business's 50 day moving average price is $137.29 and its 200-day moving average price is $149.37.

Masimo (NASDAQ:MASI - Get Rating) last issued its quarterly earnings results on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, topping the consensus estimate of $1.19 by $0.16. The company had revenue of $565.30 million during the quarter, compared to analysts' expectations of $540.56 million. Masimo had a net margin of 12.68% and a return on equity of 16.45%. Masimo's revenue was up 87.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.94 EPS. Equities analysts anticipate that Masimo will post 4.61 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on MASI. Needham & Company LLC increased their price objective on shares of Masimo from $163.00 to $179.00 and gave the company a "buy" rating in a report on Wednesday. Stifel Nicolaus reduced their target price on shares of Masimo from $175.00 to $150.00 in a report on Wednesday, May 4th. StockNews.com downgraded shares of Masimo from a "buy" rating to a "hold" rating in a research report on Wednesday. Finally, Piper Sandler upped their price target on shares of Masimo from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Masimo presently has an average rating of "Hold" and an average price target of $183.80.